Ever since Clark and Lyons introduced the first enzyme sensor five decades ago, extensive studies have been carried out to develop a range of biosensors employing the combination of biosensing molecules and transducers. The evolution from the early generation through to the current generation of biosensor research has witnessed the appearance of a number of very diversified biosensing molecules. In this review, we summarize the biomolecular engineering technology underlying the development of biosensing molecules. Among the various biosensor research targets, we focused on the development of glycated protein sensing technology. Glycated protein sensing is one of the most emergent and focused on technology in the field of diabetes diagnosis. We especially focused on the recent advances in the development of fructosyl amino acid/fructosyl peptide oxidases, which are the key enzymes in the biochemical measurement of glycated proteins, as the representative biosensing molecules to acknowledge the rewards of the current advanced biomolecular engineering technology.
Introduction
Ever since Clark and Lyons introduced the first biosensor, 1 which was an enzyme sensor employing glucose oxidase together with an oxygen electrode for glucose monitoring, extensive studies have been carried out to develop a wide range of biosensors employing the combination of biosensing molecules and transducers. The evolution from the early generation through to the current generation of biosensors has witnessed the appearance of a number of very diverse biosensing molecules, which vary tremendously in terms of origin, structure, reaction, preparation method, and their availability. Biosensor research was initially entirely dependent on the availability of biosensing molecules from natural sources. No longer limited to naturally derived biosensing molecules, we rely ever more on recombinantly prepared ones as well as biomimicking molecules. With the advances in recombinant DNA technology, robust highquality biomolecules such as enzymes and antibodies have been prepared. Protein engineering has enabled researchers to modify biomolecules for their specific biosensing purposes. Current understanding of proteins and the availability of genomic information has widened the opportunities to find ideal biomolecules from the genomic database. Moreover, recent advances in gene synthesis allows us to prepare any desired biomolecule without the traditional molecular biology procedures and without the need to obtain any source DNA.
In this review article, we summarize the biomolecular engineering technology underlying the development of biosensing molecules. From the various biosensor research targets, we focused on the development of glycated-protein sensing technology. Glycated protein sensing technology is one of the most emergent and focusedon in the field of diabetes diagnosis. We particularly focused on recent advances in the development of fructosyl amino acid/ fructosyl peptide oxidases, the key enzymes in the biochemical measurement of glycated proteins, as representative biosensing molecules and acknowledge the rewards of the current advances in biomolecular engineering.
Glycated Proteins as the Marker for Glycemic Control
Hyperglycemia is responsible for most of the symptoms and long-term complications of diabetes mellitus. Adequate glycemic control therefore results in perceived improvements in overall quality of life.
2 Furthermore, early diagnosis and regular assessment of treatment effectiveness are very important for the prevention of serious complications. 3 Self-monitoring of blood glucose, by using glucose enzyme sensors, is an integral part of a structured selfmanagement strategy for achieving target glycemic levels. However, assessing treatment effectiveness requires a method that can determine the average blood glucose concentration over an extended period.
Glycation involves a series of non-enzymatic reactions between reducing sugars and free amino groups on amino acids or proteins. The reaction proceeds through a Schiff base intermediate that can undergo a slow Amadori rearrangement to produce a relatively stable product (Fig. 1) . Glycation occurs in blood, where reaction with glucose results in the formation of the Amadori products hemoglobin A1c (HbA1c) (Fig. 2a ) and glycated albumin (Fig. 2b) , which are recognized as important glycemic control indicators of diabetes. Amadori products are also formed during the processing and storage of food products and have a significant influence on the taste, appearance, and overall quality.
Treatment assessment is increasingly done by measuring either or both glycated serum albumin, whose levels reflect the average blood glucose concentration of the preceding 12 weeks, and glycated hemoglobin HbA1c, which has been for some time the gold standard for assessing long-term control of glycemic levels in diabetes patients. HbA1c is a hemoglobin molecule in which the N-terminal valine residue of the B subunit has been modified by blood glucose (Fig. 2b) . Due to the erythrocyte's long lifetime and the slow continuous and essentially irreversible characteristics of the glycation process, 4 the relative amount of HbA1c reflects the average blood glucose concentration of the past 23 months.
Clinical laboratories have been using a number of different HbA1c measurement systems, such as ion exchange high performance liquid chromatography, immunoassay, and boronate affinity chromatography. Commercially available enzyme assay systems, based on the enzyme fructosyl amino acid oxidase (FAOD) or fructosyl peptide oxidase (FPOX), 710 have recently provided attractive alternatives for these conventional clinical tests. There is active research in trying to improve the properties of this enzyme and in developing novel FAOD/FPOX-based detection systems. FAOD/FPOX is expected to become a major component of glycated protein sensing and eventually be applied in simple, convenient, and economical detection systems for point-of-care treatment and selfmonitoring applications.
Fructosyl Amino Acid/Fructosyl Peptide Oxidases
Fructosyl amino acid/fructosyl peptide oxidases (FAODs/ FPOXs) are oxidoreductases harboring flavin adenine dinucleotide (FAD) as the cofactor. FAODs/FPOXs catalyze the oxidation of the C-N bond linking the C1 of the fructosyl moiety and the nitrogen of the amino group of fructosyl amino acids (Fig. 3) . The reaction proceeds through an unstable Schiff base intermediate, which hydrolyzes to produce glucosone and an amino acid. The enzyme's reduced FAD is then reoxidized by molecular oxygen with the release of hydrogen peroxide. Although all FAODs are unable to oxidize large glycated peptides or intact glycated proteins, some FAODs have recently been shown to have relatively high activity towards fructosyl valyl histidine (f-A Val-His), 11 which corresponds to the N-terminal fructosyl dipeptide derived from HbA1c. These enzymes are therefore referred to as fructosyl peptide oxidase (FPOX).
FAODs/FPOXs have been isolated from a number of diverse microorganisms, including bacteria, 1214 filamentous fungi, 11, 1519 and marine yeast 20 (Table 1) . FAODs can be subdivided into different groups according to origins and substrate specificity. Prokaryotic and eukaryotic FAODs form two structurally distinct groups, with very low homology between the two groups.
14 Prokaryotic FAODs are homodimers possessing a noncovalently bound FAD cofactor, and are specific for A-fructosyl amino acids, which are amino acids glycated on their A amino group. Most eukaryotic FAODs are monomers with a covalently attached FAD cofactor. Eukaryotic FAODs can be divided into three groups according to substrate specificity, those specific for A-fructosyl amino acids, those specific for X-fructosyl amino acids, and those that oxidize both A-and X-fructosyl amino acids at comparable rates (Table 1 ).
Searching for FAOD/FPOX
The traditional way of finding novel molecules for biosensing is the screening of enzymes from natural habitats. Microorganisms (both eukaryotes and prokaryotes) are currently the major source for diagnostic enzymes. The traditional method of screening involves the empirical examination of thousands of samples from various locations. Basically, screening of microorganisms is carried out by subjecting an environmental sample to selective pressure using a specifically designed enrichment medium. By repeating microbial cultivation in the selective medium, microorganisms expressing the target enzyme are selected. Below, we describe our representative enzyme screening of FAOD leading to its recombinant production in Escherichia coli.
Although FAODs/FPOXs had initially been reported from a number of different microorganisms, they were only isolated from Electrochemistry, 80(5), 293298 (2012) terrestrial samples. Considering that glycation of proteins occurs in various living organisms, Amadori compounds should also be distributed in the marine environment. Consequently, a variety of organisms capable of metabolizing Amadori compounds were expected to exist in the marine environment. Coastal sea water samples were collected, concentrated, and then spread onto agar plates with a selection medium containing Amadori compounds as either the sole carbon or nitrogen source. This selection procedure was repeated until colony formation was observed, at which point colonies were inoculated in liquid selection medium. The resulting microbial cell culture was then disrupted and investigated for its ability to oxidize fructosyl amino acids. These steps were repeated until we obtained a stable culture producing enzyme capable of oxidizing fructosyl amino acids. By following the above screening process, we have succeeded in isolating a marine budding yeast strain, Pichia N1-1, producing FAOD. 20 The FAOD enzyme from Pichia N1-1 was then purified and the amino acid sequence of a proteolytic digestion was determined. A set of degenerated oligonucleotide primers were designed based on the partial amino acid sequence to carry out inverse PCR using as template a cDNA library prepared from mRNA isolated from Pichia N1-1. The entire structural gene of N1-1 FAOD was thus cloned and used for the recombinant expression of N1-1 FAOD in E. coli as the host microorganism. 39 Similarly, we have succeeded in the isolation, cloning, and recombinant expression of soil prokaryote-derived enzyme, FV1-1 FAOD.
14 A number of biosensor studies were carried out using thus prepared recombinant N1-1 and FV1-1 FAODs.
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There has been continuous interest in searching for novel FAODs/FPOXs. The current availability of extensive microorganism genome information has made it possible to search for novel enzymes with desirable properties by genome-wide screening approaches. We recently demonstrated the first achievement of this approach for identifying a novel FPOX, by searching for "FAOD/ FPOX motifs" proposed based on information from our 3D structural model and sequence alignments. 26 An amino acid sequence alignment of known FAODs/FPOXs revealed three sequence motifs, motif 1 (AGxDxNK), motif 2 (GFFxExxE), and Among these candidates, a putative protein gene from Phaeosphaeria nodorum was synthesized and expressed in E. coli, leading to the production of an enzyme with activity toward glycated molecules, with remarkably high activity toward f-A Val-His. This novel FPOX, designated as PnFPOX, is the first enzyme that reacts with glycated molecules that has been identified through genomewide screening.
Engineering of FAOD/FPOX

Improving substrate specificity
Protein engineering approaches provide many opportunities to improve the existing enzymes to fit a particular biosensing application. Conventional protein engineering approaches aim to modify enzymatic properties, such as substrate specificity and enzyme stability, while maintaining catalytic activity toward target molecules. We initiated the improvement of substrate specificity of FAOD by a rational design approach, despite the absence of any three dimensional structural information. We set out to improve the substrate specificity of the N1-1 FAOD, which naturally reacts with f-A Val and f-X Lys at comparable rates. By creating a structural model and carrying out docking studies, we identified the amino acid residue Asn354 as interacting with the potential substrates. 33, 34 Substitution of Asn354 to histidine or lysine simultaneously increased the enzyme's activity towards f-A Val and decreased that towards f-X Lys, thus greatly improving its specificity for f-A Val. Similarly, substitution of the His51 residue also produced mutants with significantly improved specificity for f-A Val. 35 The combination of As354 and His51 amino acid substitutions resulted in an FAOD mutant with greatly improved f-A Val specificity. Our predicted structural model and our rational design approach were both further validated by the recent elucidation of the crystal structure of the FAOD (amadoriase II) from the fungus Aspergillus fumigatus.
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Another group also reported the improvement of FAOD properties by carrying out random mutagenesis and screening for potentially useful mutants using an in vivo colorimetric plate assay. The substitution of a single amino acid residue in the FAOD from Fusarium oxysporum caused a great decrease in activity with f-A Val while only slightly affecting its activity with f-X Lys, thus greatly enhancing its f-X Lys specificity. 29 In contrast, substitution of one residue in the FAOD from Ulocladium sp. JS-103 resulted in a 14-fold greater preference for f-A Val compared to the wild-type enzyme. 24 A different group also used random mutagenesis and in vivo colorimetric plate screening, introducing a total of five mutations, to improve the thermostability of a Corynebacterium FAOD, rendering it stable at 45°C. 44 Using the same directed evolution approach, the introduction of a total of six amino acid substitutions greatly improved the thermostability of a fungal (Coniochaeta sp.) FAOD. 45 
Creating dehydrogenases from oxidases
We recently reported a novel protein engineering study, setting out with the unique mission to create the first ever fructosyl amino acid/peptide dehydrogenase from an FAOD/FPOX. 46, 47 An amperometric sensor employing FAOD/FPOX is ideally suited for creating a simple, convenient, and economical biosensor to measure glycated proteins for point-of-care treatment or self-monitoring applications. The use of an artificial electron acceptor (mediator) allows us to apply a lower potential, thus rendering the measurements less prone to unfavorable interference by side-reactions. Unfortunately, the measurements by electron-mediator-type electrochemical monitoring systems based on oxidases are inherently influenced by the amount of oxygen dissolved in the sample. The high oxygen reactivity of FAOD/FPOX limits their potential utility for biosensor applications employing artificial electron mediators. In this respect, oxidases that are less oxygen-sensitive would have great advantages for the development of amperometric enzyme sensors using artificial electron acceptors (Fig. 4) .
Investigation of the active-site structure, based on our 3D model of the FAOD from the marine yeast Pichia sp. N1-1 and the crystal structure of amadoriase II from the fungus A. fumigates, revealed significant structural similarities between eukaryotic FAODs and bacterial monomeric sarcosine oxidase. 46 The most significant similarity was the geometry of three residues, highly conserved in FAODs, located in the vicinity of the flavin ring si-face, the side opposite the substrate-binding site (Fig. 5) . These residues in monomeric sarcosine oxidase form a hydrogen bond network with FAD and water molecules, and is predicted to be a proton relay system (PRS) that might transfer electrons from reduced FAD to oxygen. The corresponding residues in N1-1 FAOD (Asn47, Lys48 and Lys269) are conserved in all known eukaryotic FAODs and may form a similar PRS in these enzymes. 46 We carried out site-directed mutagenesis on putative proton relay system (PRS) residues of two eukaryotic FAODs in order to alter their availability of electron acceptor. 46 The wild-type N1-1 FAOD shows almost identical enzymatic activities regardless of whether the final electron acceptor is oxygen or an artificial electron mediator. Some mutants showed at least 2-fold higher dye-mediated dehydrogenase activity than oxidase activity. Especially, the Asn47Ala mutant of N1-1 FAOD showed a drastic decrease in oxidase activity, to about 15% of the wild-type level, whereas it retained 60% of its dye-mediated dehydrogenase activity. Consequently, the Asn47Ala mutant shows higher activity when an artificial electron mediator is used as the electron acceptor instead of oxygen, with an over 4-fold greater dehydrogenase activity than oxidase activity. Similarly, the Asn52Ala substitution on amadoriase II showed a drastic decrease in oxidase activity while retaining more than 40% of its dye-mediated dehydrogenase activity, resulting in a 3.5-fold higher dye-mediated dehydrogenase activity than oxidase activity. 46 Therefore, the amino acid substitution into a strictly conserved Asn residue located in the putative PRS of FAODs resulted in considerable decreases in the oxidase activity while retaining a substantial portion of their dye-mediated dehydrogenase (2012) activity, thereby essentially creating fructosyl amino acid "dehydrogenases" from oxidases.
On the basis of this success, the construction of a fructosyl peptide "dehydrogenase" from FPOX was also carried out. 48 Primary structural alignment suggested that the putative PRS residues are also conserved among the FPOXs. Saturation mutagenesis at the corresponding residue of PnFPOX, Asn56, produced one mutant (Asn56Ala) that showed increased dehydrogenase activity toward f-A Val and a decrease in oxidase activity to below 20% of wild type. Moreover, the dehydrogenase activity toward f-A Val-His is also higher than the oxidase activity. Considering the lowered K m value of Asn56Ala when measuring dehydrogenase activity, this enzyme is expected to demonstrate much superior properties when utilized for electrochemical measurement.
Enzyme sensors employing either wild type or the Asn56Ala mutant of PnFPOX were constructed using mPMS as the electron mediator and f-A Val-His as the substrate. 48 The impact of dissolved oxygen on the sensor response was investigated, by carrying out measurements either under normal atmospheric conditions or under argon. When employing the wild-type PnFPOX, the response current clearly increased following the addition of the f-A Val-His substrate, but was barely detectable under normal air atmosphere. In contrast, the response current of the enzyme sensor employing Asn56Ala mutant of Pn FPOX showed a clear concentrationdependent increase under either condition. The enzyme sensor employing Asn56Ala PnFPOX was not affected by the presence of physiologically relevant dissolved oxygen concentrations.
Conclusion
We summarized the biomolecular engineering technology underlying the development of biosensing molecules, focusing on those employed for sensing glycated proteins. The aforementioned principles and achievements are not limited to within the engineering of molecules for glycated protein biosensing. The screening of biosensing molecules has been shifting from the traditional microbiology and molecular biology approaches to genome-wide database screening and synthetic gene approaches. The alteration of enzymatic properties is not limited to changing the substrate specificity or stability, but creating dehydrogenases from oxidases is now possible. The current exponentially growing genomic and protein structure/function information, together with the availability of various powerful simulation and prediction tools and cost effective gene synthesis, allow us to design truly tailor-made molecules for biosensing.
